Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25

Maryse Leost, Christiane Schultz, Andreas Link, Yong Zhong Wu, Jacek Biernat, Eva Maria Mandelkow, James A. Bibb, Gretchen L. Snyder, Paul Greengard, Daniel W. Zaharevitz, Rick Gussio, Adrian M. Senderowicz, Edward A. Sausville, Conrad Kunick, Laurent Meijer

Research output: Contribution to journalArticlepeer-review

341 Scopus citations


Paullones constitute a new family of benzazepinones with promising antitumoral properties. They were recently described as potent, ATP-competitive, inhibitors of the cell cycle regulating cyclin-dependent kinases (CDKs). We here report that paullones also act as very potent inhibitors of glycogen synthase kinase-3β (GSK-3β) (IC50: 4-80 nM) and the neuronal CDK5/p25 (IC50: 20-200 nM). These two enzymes are responsible for most of the hyperphosphorylation of the microtubule-binding protein tau, a feature observed in the brains of patients with Alzheimer's disease and other neurodegenerative 'taupathies'. Alsterpaullone, the most active paullone, was demonstrated to act by competing with ATP for binding to GSK-3β. Alsterpaullone inhibits the phosphorylation of tau in vivo at sites which are typically phosphorylated by GSK-3β in Alzheimer's disease. Alsterpaullone also inhibits the CDK5/p25-dependent phosphorylation of DARPP-32 in mouse striatum slices in vitro. This dual specificity of paullones may turn these compounds into very useful tools for the study and possibly treatment of neurodegenerative and proliferative disorders.

Original languageEnglish (US)
Pages (from-to)5983-5994
Number of pages12
JournalEuropean Journal of Biochemistry
Issue number19
StatePublished - 2000


  • Alzheimer's disease
  • Cyclin-dependent kinase 5
  • Glycogen synthase kinase-3
  • Paullones, kinase inhibitors

ASJC Scopus subject areas

  • Biochemistry


Dive into the research topics of 'Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25'. Together they form a unique fingerprint.

Cite this